AbbVie shares fell on Tuesday following a lawsuit by the California Department of Insurance alleging that the pharmaceutical company gave healthcare providers kickbacks to prescribe its arthritis drug Humira.
The suit alleges that AbbVie provided cash, trips and other gifts to healthcare providers as incentives to prescribe the drug.
This story is developing. Please check back for updates.